ClinicalTrials.gg
Status unknownNCT04734574Updated Mar 28, 2023

Methods of Confirmation of Brain Death

An observational study in Brain Death and Organ Donation, sponsored by Brno University Hospital. Status unknown at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-28.

Sponsored by Brno University Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to describe the use of methods confirming brain death in the real clinical practice of the transplant program in the Czech Republic.

Read the detailed description

Organ donation is possible in the Czech Republic only after meeting the legislative requirements. These require confirmation of brain death by one of the statutory methods before organ harvesting. The use of these methods in clinical practice has not yet been described.The aim of this retrospective observational study is to describe the use of these methods in the real clinical practice of the transplant program in the Czech Republic, taking into account the legislation of other European countries.

02

Conditions studied

  • Brain Death
  • Organ Donation

Browse trials for

03

In context

Brain Death

74 studies on the registry are indexed under Brain Death; 10 are open to participants now.

This study's planned enrollment of 60 is below the median of 80 across 33 observational studies indexed under Brain Death.

Browse Brain Death studies →

Lead sponsor

Brno University Hospital is the lead sponsor of 91 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult critically ill patinets with confirmed brain death admitted to university hospital who become brain death organ donor.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age ≥18 years
  • organ donor

Exclusion criteria

Exclusion Criteria:

  • age under 18 years
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
60 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Angiography

    Cerebral panangiography

    Time frame: within 24 hours after the onset of signs of brain death

  2. Brainstem auditory evoked potentials

    Brainstem auditory evoked potentials

    Time frame: within 24 hours after the onset of signs of brain death

  3. Brain scintigraphy

    Brain scintigraphy

    Time frame: within 24 hours after the onset of signs of brain death

  4. Cerebral computed tomography angiography

    Cerebral computed tomography angiography

    Time frame: within 24 hours after the onset of signs of brain death

  5. Transcranial Doppler ultrasonography

    Transcranial Doppler ultrasonography

    Time frame: within 24 hours after the onset of signs of brain death

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2022 (actual). Primary completion is estimated for Dec 2023, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2021
First posted
Feb 2, 2021
StartActual
Apr 1, 2022
Primary completionEst.
Dec 1, 2023
CompletionEst.
Dec 30, 2023
Last update
Mar 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04734574
Lead sponsor
Brno University Hospital
Responsible party
Ondrej Hrdy (Principal Investigator, Brno University Hospital) — Principal investigator
First posted
Feb 2, 2021
Start date
Apr 1, 2022
Primary completion
Dec 1, 2023 (estimated)
Completion
Dec 30, 2023 (estimated)
Last update
Mar 28, 2023

Study contacts

Ondrej Hrdy, M.D.
Contact
hrdy.ondrej@fnbrno.cz
532233850 ext. +420
Jaroslav Duba, M.D.
Contact
duba.jarosalv@fnbrno.cz
532233850 ext. +420
Roman Gal, M.D., Ph.D.
study chair · University Hospital Brno

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion